ReShape Lifesciences Inc. (NASDAQ:RSLS) Short Interest Up 40.4% in January

ReShape Lifesciences Inc. (NASDAQ:RSLS) was the target of a significant increase in short interest in the month of January. As of January 31st, there was short interest totalling 22,600 shares, an increase of 40.4% from the January 15th total of 16,100 shares. Based on an average daily trading volume, of 59,800 shares, the short-interest ratio is presently 0.4 days. Approximately 3.3% of the company’s stock are sold short.

ReShape Lifesciences Price Performance

RSLS traded down $0.21 during trading on Friday, reaching $2.33. 123,469 shares of the stock traded hands, compared to its average volume of 47,470. ReShape Lifesciences has a fifty-two week low of $2.32 and a fifty-two week high of $29.00. The stock’s 50-day simple moving average is $4.21 and its two-hundred day simple moving average is $6.17.

ReShape Lifesciences Company Profile

ReShape Lifesciences Inc provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; Lap-Band 2.0 System, an adjustable postoperatively to increase or decrease the pressure to the band in order to optimize an individual's comfort and therapy effectiveness; and ReShape Calibration Tubes, that fits the lesser curvature of the stomach to reach the pylorus.